Elixinol Global Ltd's (ASX:EXL) (OTCQB:ELLXF) (FRA:E8M) Oliver Horn speaks to Proactive's Andrew Scott soon after announcing they've entered into a binding agreement for its subsidiary Elixinol BV to acquire CannaCare Health GmbH, a company incorporated in Germany for an upfront consideration of €9 million in cash and shares. The acquisition positions Elixinol as a leading pan-European CBD business and is expected to fast-track revenue and its path to profitability growth.
Elixinol Global says CannaCare acquisition has potential to accelerate revenue growth and scale
